From regional excellence to worldwide distinction – thriving as an international pharma powerhouse - GM PHARMA's quarter century of care and better health
GM PHARMA celebrates its 25th anniversary of continuous development with numerous successes and ambitious plans:
GM PHARMA's solid dosage forms manufacturing site in Tbilisi, Georgia, is the largest pharmaceutical plant in the Caucasus region.
The company holds national and international certificates, permits and licenses required for pharmaceutical manufacturing, including:
☑️ Good Manufacturing Practice – National GMP (Georgia)
☑️ Good Manufacturing Practice – GMP PIC/S (International)
☑️ Quality Management – ISO 9001:2015 and ISO 17025:2017/2018
With > 130 brands and > 220 dosage forms in its portfolio GM PHARMA holds one of the broadest product portfolio in the region covering almost all dosage forms and therapeutic areas, including a wide range of food supplements.
Since 2017, GM PHARMA has been the market leader in the Georgian pharmaceutical market, in terms of both, sales value and sales units.
GM PHARMA exports more than 100 products globally and has representative offices in 7 countries (Uzbekistan, Tajikistan, Kyrgyzstan, Armenia, Moldova, Azerbaijan and Kazakhstan).
GM PHARMA is among the top 5 foreign pharma companies by value sold in Uzbekistan.
GM PHARMA employs more than 600 professionals including those employed in its export countries.
More than 12 million patients are treated with GM PHARMA products in Georgia and the company's international, export markets every year, which shows the recognition of the company by consumers and healthcare specialists.
GM PHARMA has more than 15 ongoing R&D (research and development) projects in its pipeline. GM PHARMA is committed to consistently provide products that meet or exceed the requirements and expectations of our customers and patients.
25 years after its founding, GM PHARMA's goal is still ambitious – today the main priority is to obtain the EU GMP certificate and becoming an International Pharma Powerhouse, successfully transitioning from regional excellence to the worldwide distinction and reinforcing Georgia’s reputation as a center for business development and healthcare advancement.
The company's history began 25 years ago, in the late '90s, when Georgia faced a significant shortage of pharmaceutical products. This challenging period sparked the initiative to establish a global pharmaceutical company in Georgia, adhering to international standards.
Every crisis can be an opportunity and become the beginning of a better future – and that's exactly how GM PHARMA was born. Despite the difficulties at that time, the set goal became a reality in February 2000 through tireless work and effort, with the first medication, Rifampicin capsules, were developed at GM PHARMA.
Since then, for 25 years, GM PHARMA has been serving those who need it most and they are patients! Since its founding, the company's mission and values have remained unchanged – based on scientific approaches and industry best practices, continuous improvement of quality and products, and the production and supply medicines that improve and prolong patients’ lives.